Phone-Based navigation could boost breast cancer detection in kenya

NCT ID NCT07764796

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This study tests whether mobile health (m-Health) patient navigation—using phone apps for education, reminders, and motivation—can help more women in Kenyan primary care clinics get screened for breast cancer. The trial involves 800 women and aims to improve access to mammography and clinical breast exams, which are underused despite being available. By linking patients to screening and follow-up care, the approach could lead to earlier detection and better outcomes for breast cancer, a disease that is highly curable when caught early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Mobile health (m-Health) patient navigation strategies, including digital platforms and tools for education, reminders, navigation, and motivation
What this could lead to
If effective, this approach could increase breast cancer screening rates and early detection in Kenya, potentially saving lives by catching cancer when it is most treatable.
What could go wrong
This is an early-stage implementation study, so it may not show a clear benefit. Success depends on real-world factors like phone access, health system readiness, and patient engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Emory University Hospital/Winship Cancer Institute

    RECRUITING

    Atlanta, Georgia, 30322, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.